Provided by Tiger Trade Technology Pte. Ltd.

GW Pharmaceuticals PLC

218.96
0.0000
Volume:- -
Turnover:- -
Market Cap:6.91B
PE:-98.44
High:218.96
Open:218.96
Low:218.96
Close:218.96
52wk High:219.57
52wk Low:87.07
Shares:31.54M
Float Shares:30.54M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2244
EPS(LYR):-1.8572
ROE:-7.92%
ROA:-3.55%
PB:9.32
PE(LYR):-117.90

Loading ...

Jan 12, 2021

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2020

Major Issues Report

8-K - Current report
Sep 10, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2020

Major Issues Report

8-K - Current report
May 27, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 27, 2020

Major Issues Report

8-K - Current report
May 12, 2020

Major Issues Report

8-K - Current report
May 11, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 27, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 04, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 03, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Jan 13, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Dec 09, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Nov 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]